Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results from the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial

BACKGROUND: Kidney transplant recipients, like other patients with chronic kidney disease (CKD), experience excess risk of cardiovascular disease (CVD) and elevated total homocysteine (tHcy) concentrations. Observational studies of patients with CKD suggest increased homocysteine is a risk factor fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Circulation
Autors principals: Bostom, Andrew G., Carpenter, Myra A., Kusek, John W., Levey, Andrew S., Hunsicker, Lawrence, Pfeffer, Marc A., Selhub, Jacob, Jacques, Paul F., Cole, Edward, Gravens-Mueller, Lisa, House, Andrew A., Kew, Clifton, McKenney, Joyce L., Pacheco-Silva, Alvaro, Pesavento, Todd, Pirsch, John, Smith, Stephen, Solomon, Scott, Weir, Matthew
Format: Artigo
Idioma:Inglês
Publicat: 2011
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887854/
https://ncbi.nlm.nih.gov/pubmed/21482964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.110.000588
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars